Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 7Recruiting 5Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 2Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Prostatic Neoplasms 1Neurofibrosarcoma 1Multiple Myeloma 1Lung Neoplasms 1Liposarcoma 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Inflammatory Breast Neoplasms 1Histiocytoma, Malignant Fibrous 1Hematopoietic and Lymphatic System Neoplasm 1Hemangiosarcoma 1Gliosarcoma 1Glioblastoma 1Fibrosarcoma 1Dermatofibrosarcoma 1Colorectal Neoplasms 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 15daratumumab 13Lenalidomide 9Bortezomib 8pomalidomide 6Calcium Dobesilate 5Cyclophosphamide 4carfilzomib 3belantamab mafodotin 3tocilizumab 2isatuximab 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Specimen Handling 2Melphalan 2Maintenance 2Exercise Therapy 2Drug Therapy 2CT103A chimeric antigen receptor 2Biopsy 2zanubrutinib 1trametinib 1talquetamab 1selinexor 1pembrolizumab 1ixazomib 1ibrutinib 1iberdomide 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Multiple Myeloma × X-Rays × Clear all
NCT04579523 2026-03-13

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Fred Hutchinson Cancer Center

Phase 1 Not yet recruiting
30 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡